All posts by Scott Gavura

Scott Gavura, BScPhm, MBA, RPh is committed to improving the way medications are used, and examining the profession of pharmacy through the lens of science-based medicine. He has a professional interest is improving the cost-effective use of drugs at the population level. Scott holds a Bachelor of Science in Pharmacy degree, and a Master of Business Administration degree from the University of Toronto, and has completed a Accredited Canadian Hospital Pharmacy Residency Program. His professional background includes pharmacy work in both community and hospital settings. He is a registered pharmacist in Ontario, Canada. Scott has no conflicts of interest to disclose. Disclaimer: All views expressed by Scott are his personal views alone, and do not represent the opinions of any current or former employers, or any organizations that he may be affiliated with. All information is provided for discussion purposes only, and should not be used as a replacement for consultation with a licensed and accredited health professional.

Author

  • Scott Gavura, BScPhm, MBA, RPh is committed to improving the way medications are used, and examining the profession of pharmacy through the lens of science-based medicine. He has a professional interest is improving the cost-effective use of drugs at the population level. Scott holds a Bachelor of Science in Pharmacy degree, and a Master of Business Administration degree from the University of Toronto, and has completed a Accredited Canadian Hospital Pharmacy Residency Program. His professional background includes pharmacy work in both community and hospital settings. He is a registered pharmacist in Ontario, Canada.

    Scott has no conflicts of interest to disclose.

    Disclaimer: All views expressed by Scott are his personal views alone, and do not represent the opinions of any current or former employers, or any organizations that he may be affiliated with. All information is provided for discussion purposes only, and should not be used as a replacement for consultation with a licensed and accredited health professional.

New Cautions About Vitamin B6 and Peripheral Neuropathy

Two countries are putting warnings and limits on Vitamin B6 supplements.

/ August 13, 2026
A syringe with a needle is placed in front of three small glass vials containing a clear liquid, all set on a white surface.

The FDA vs. Compounding Pharmacies: GLP-1 Edition

The FDA is determined to stop the sale of compounded GLP-1 drugs

/ July 30, 2026

Science vs. Hype: The Unproven Promise of NAD+ IV Therapy

Two new papers and renewed safety concerns for this popular (yet unproven) therapy.

/ July 16, 2026

Is the Homeopathic Industry “On the Ropes”?

The U.S. homeopathic industry is under growing regulatory and legal pressure.

/ July 2, 2026
A close-up of a weathered gravestone with the letters "R.I.P." engraved on its surface, symbolizing rest in peace. The stone appears aged and has a slightly damp texture.

99 Ways to Die – And How to Avoid them

An entertaining guide to death, with tips on how to avoid it, from an emergency medicine doctor.

/ June 18, 2026
DNA Image

Revolutions in Drug Delivery

New medicines are getting better. But so is our ability to get them where they need to go.

/ June 4, 2026
A person kneels on the floor, wearing a teal sports bra and red leggings with the word "Guess" printed on them. They are holding a small red weight, engaging in a fitness activity on a light-colored wooden surface.

Hyaluronic Acid Adulteration

There may be undisclosed ingredients in your hyaluronic acid supplement.

/ May 7, 2026
A simplified, cutaway illustration of a mitochondrion shows an orange outer membrane and blue folded inner membrane structures called cristae.

Do our mitochondria need support?

Many products have claims to “support” your mitochondria. For healthy adults, these claims remain largely speculative and unproven.

/ April 9, 2026

Geopolitics and Drug Shortages

The war in Iran is challenging pharmaceutical supply chains and revealing strains in the system.

/ March 26, 2026
Scrabble tiles spell out the word "OZEMPIC" on a white marble surface, surrounded by scattered tiles with random letters.

Generic GLP-1s are coming, but Americans don’t want to wait

Compounding pharmacies are illegally selling GLP-1 drugs, and the FDA is determined to shut that pathway down.

/ March 12, 2026